Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Age equal or superior to 40 years and under 65 years~* Clinical menopause - last menstrual period from 1 to 5 years from the date of recruitment~* FSH measurement\> 25 IU / ml, estrogen \<20 æg / ml~* Patients with vaginal atrophy and clinical and / or sexual symptoms~* Patients without hormonal treatment for at least five years~Exclusion Criteria:~* Whole Hymen~  * Altered oncology cytology of the cervix and / or vagina~ * Vaginal infections~ * Connective tissue diseases~ * Immunosuppression~ * Coagulation change~ * Diabetes Mellitus~ * Thyroid diseases~ * Use of systemic or local feminine hormones~ * Use of other substances with estrogenic properties

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Fractional CO2 LASER (Type: ACTIVE_COMPARATOR): Vaginal fractional CO2 LASER 3 sessions applications
- Microablative fractional radiofrequency (Type: ACTIVE_COMPARATOR): Vaginal Microablative fractional radiofrequency 3 sessions application
- Promestriene Vaginal (Type: ACTIVE_COMPARATOR): Promestriene vaginal use during 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).